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LE’l-T?ZRS TO THE EDITOR -.- 
Stress Echocardiography for Diagnosis of 
Coronary Artery Disease 
The report by Dagianti et al. (1) makes the point of comps’iz~ crercise 
echocardiography, dobutamine echocardiography and dipyridamole 
echocardiography in the diagnosis of coronary artery disease. The 
topic is interesting, but the report may already appear old at birth. In 
fact, the field of pharmacologic stress echocardiography is in rapid 
evolution. 
In the continuing quest for ideal diagnostic accuracy, pharmaco- 
logic stresses have quickly moved over the years from low dose to high 
dose regimens and eventually to atropine coadministration (2-4). 
which optimizes sensitivity. As a consequence. the pharmacologic 
stress protocols used by the authors can be considered obsolete, 
although this point was not mentioned as a study limitation. If atropine 
protocols are used, the secsitRity gap is filled because dobutamine- 
atropine and dipyridamole-atropine have a similar sencitivity (5). 
This sensitivity is particularly important because the issue of 
sensitivity was the key factor in the conclusion of Da& nti et al. that 
exercise e&cardiography should represent the applaach of first 
choice, dobutamine ihe second and dipyridamole the third in their 
diagnostic algorithms. In addition, the authors did not cite the study 
with the largest patient series (136 pa!ients), in which exercise, high 
dose dobutamine and high dose Jipyridamole were compared by 
Beleslin et al. (6), who found similar accuracy (82% vs. 77%, respec- 
tively) for dobutamine versus dipyridamole. After the publication of 
the report by Dagianti et al., additional reports appeared that docu- 
mented the nearly identical accuracy of high dose dipyridamole and 
high dose dobutamine (7,&). 
Finally, the authors did not cite their own previously published data 
on dipyridamoie echocardiography, which reported a striking 92% 
sensitivity and 100% specificity with transesophageal echocardiogra- 
phy (9). In the present study, the sensitivity falls to 55%, and even 33% 
in pztients with previous myocardial infarction. Rather than pointing 
out the merits of transesophageal versus transthoracic echorardiogra- 
phy, the present study may be the most obvious demonstration of a 
statemen’ reported by Picano (4) regarding the two basic laws of 
published reports on stress echocardiography: 
1. NO test is so bad that you cannot make it look good. 
2. NO test is so good that you cannot make it look bad. 
Probably before drawing any conclusion on the relative merits of 
various stress tests, data obtained with state of the art protocols are 
warranted. The risk may be that useless data may be generated if 
obsolete pmtocols are administered (and even proposed), ignoring 
hard evidence reported by others. 
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The vast rcientific and clinical potential of stress echocardiography has led 
to the publication of interesting reports on the diagnostic value of single 
stress ecbocardiographic modalities. However, for the practicing caniiol- 
ogist. the choice of which stress test may be better for his or her patient is 
the most compelling issue. This issue can be adequately addressed only by 
studies like our own (1) that directly compare diagnostic efficacy by having 
the same patient undergo exertion, tipyridamole and dobutamine echo- 
cardiography, an approach that was lacking in published reports on streo 
e&cardiography. Unfortunately, such studies are diicult to perform in 
a large patient series because of ethical and economical reasons. Our 
results compare well with most previous investigators and with those 
reported in a recent study by Beleslin et al. (2). which we did not quote 
because it published after the submission of our study (1). We want to also 
point out that in that study, recently published in Cinx&ion, atmpine 
coadmmistmtion, recently proposed to enhance the sensitivity of pharmd- 
cologic stress echocardiography, was not included in the dobutamine 
stress protocol; therefore, according to Tortes this study may also already 
appear old at birth. However, superiority of dobutamine-atropine echc- 
cardiography over exercise echocardiography cannot be inferred for lack 
of comparative studies. In our study, atmpine was not used because we 
wanted to investigate the effects of dobutamine on hemodynamic vari- 
ables and on the behavior of left ventricular volumes during the test that 
would be affected by the choline@ antagonist. Insofar as concerns the 
hard evidence on the relative me&x of dipyridamole echocardiigraphy by 
Torres, we point out that in a comparative study by Picano et al. (3), no 
more recent than ours and quoted in our study, exercise and dipyridamole 
eehocardiiphy yielded similar dia@tic results, whereas MarangeNi 
et al. (4) recently obtained signiitiy higher sensitivity values for 
exercise than for dipyridamole. We would lie to mention the most recent 
report of a higher diagnostic value for exercise echocardiogmphy and 
dobutamine eehocardiograpby over d&r&mole and even adenosine 
echocardiography (5). Accordingly, in our report we mentioned our 
previous experience using the tramesophageal approach (6) with the view 
OfunderliningtheneedofimprovingthesensithityvaluesofdiWridamole 
eehocatiography. Nevertbetess, in that study the se&iv&y for one-vessel 
disease was also low (67%). 
As concerns the comment about the results of our study (I) in 
patients with a previous myocardiai infarction, we assessed the efficacy 
One consideratton that Cheng adduced for his argument that all 
of the three tests in detecting the extent of coronary artery disease: The 
patients with mitral valve prolapse should receive prophylaxis was that 
accuracy values, not the sensitivity, in predicting the extent of coronary 
“antibiotic prophylaxis against infective endocarditis is highly cost-, 
artery disease were 71% fsr exe&e. 75% for dobutamine and 33% for 
effective,” quoting Gould and Buckingham (4). Analysis of the latter 
dipyridamole. 
report suggests that this conclusion i- fat from sccuri. 
First. Gould and Buckingham conceded that “there is no direct 
Again, from a c!inica! perspective and after personal experience 
spanning nearly two decades, our view is that exercise testing firmly 
bears comparison with the easier to perform pharmacologic stress. 
Physical exertion is a better stress than dipyridamole, dobutamine and 
pacing according to a recent experimental study (7) in that it causes the 
most severe contractile dysfunction, and in clinical practice it main- 
tains the unique capability of providing physiologic information on the 
patient’s exercise capacity. Pharmacologic stress echocardiography, 
notably using dobutamine, could thus supplement rather than supplant 
the more traditional diagnostic role of exercise testing in the evalua- 
tion of chest pain. In light of the tangible difference between 
dipyridamole- and exercise-induced ischemic phenomena, dipyrida- 
mole being the coronary vasodilator liable to trigger ischemia in 
circumstances where no other physiologic activity can elicit the same 
response, in our opinion it is proper to wonder whether dipyridamole 
may be put to fruitful clinical use either as a means of diagnosing 
myocardial ischemia or as a valid tool for prognosis. 
proof that antibiotic prophylaxis is efficacious.” Lacking that, there is 
no way to prove their assertion that it is highly cost-effective. Second, 
they askcrtor’ that 15% of cases of infective endocarditis ere attribut- 
able tc drntrl procedures, citing an article by Bayliss et al. (5). Bayliss 
et al. rcgorted a figure of 13.7% for cases that occurred as long as 3 
months after a dental procedure. Three weeks would have been a more 
appropriate interval, according to Starkebaum et al. (6) who found 
that symptoms began within 2 weeks in 84% of the cases that they 
studied. When Bayliss et al. used an interval of c;l month to link a 
dental procedure with endocarditis, only 3.7% could be attributed to 
the dental procedure. This is nearly identical to the ra,< of 3.6% that 
I found after a literature search that included 1.322 cases (7). Another 
consideration in calculating the effectiveness of prophylaxis is the 
number of endocarditis cases with known heart disease before the 
infection, and that was only 42.5% (i.e.. only 1.64 of all cases of 
endocarditis could have been prevented if prophylaxis had &en 
successful). Considering that a number of cases that have had prophy- 
laxis nevertheless develop endocarditis even when the offending 
organism was susceptible to the antibiotic used (8), the percent ofceses 
of endocarditis that could be prevented is surely <1.5%. This small 
number may explain why the incidence of endocarditis has not changed 
significantly since the introduction of chemoprophylaxis (S), which 
caused Bayliss et al. to argue that better dental care and hygiene are 
much more important than chemoprophylaxis. 
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Antibiotic Prophylaxis Against Infective 
Endocarditis in Mitral Valve Prolapse 
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Nevertheless. all the studies mentioned here advocate chemopro- 
phylaxis for dental procedures. One good reason is to avoid litigation. 
At the least, we should make prophylaxis as simple as possible. 
Fortunately, the American Heart Association in 1991 abandoned their 
recommendation for intravenous antibiotics for high risk patients 
which was never practical for most parts of the countrv. It is alw 
reasonable to abandon the second dose of amoxicillim,~in that the 
proven duration of bacteremia after extraction is only 15 mm (7). The 
British have used only a single dose for some years (5). But for 
cost-effectiveness, chemoprophylaxis should receive a lower priority 
from cardiologists than good dental health. 
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questions that we have all stru&d with. Should we recommend 
antibiotics for all such patients or only for those who demonstrate 
audible murmurs of mitral regngitation. as recommended by the 
American Heart Association gutdelirtes (3)? (What about the many 
patients who have no clii no audible murmur and no prolapse but 
have mild mitral regurgitation by Doppler at test?) 
